Marker Therapeutics, Inc. (MRKR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.81M |
| Enterprise Value | 6.74M |
| P/E Ratio | -2.04 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 7.06 |
| Price/Book Ratio | 1.92 |
| Enterprise/Revenue | -0.06 |
| Enterprise/EBITDA | 0.01 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -5.2 |
| Operating Margin | -5.9 |
AD
Management Effectiveness
| Return On Assets | -0.63 |
| Return On Equity | -0.73 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.11 |
| Gross Profit | 0 |
| EBITDA | -12.44M |
| Net Income | -12.16M |
| Diluted EPS | -0.79 |
Balance Sheet
| Total Cash | 14.92M |
| Total Cash/Share | 0.77 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.79 |
| Book Value Per Share | 0.71 |
Price History
| 52-Week Change | -3.52 |
| 52-Week High | 4.07 |
| 52-Week Low | 0.81 |
| Moving Average 50 Days | 1.47 |
| Moving Average 200 Days | 1.34 |
Statistics
| Average Volume | 94,959 |
| Shares Outstanding | 10.8M |
| % Held by Institutions | 25.49 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 27, 2023 |
AD
